NASDAQ:EYES - Second Sight Medical Products Stock Price, Forecast & News

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

Second Sight Medical Products Inc (NASDAQ:EYES) posted its quarterly earnings results on Thursday, November, 14th. The medical device company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The medical device company had revenue of $0.47 million for the quarter, compared to analyst estimates of $0.94 million. Second Sight Medical Products had a negative return on equity of 201.34% and a negative net margin of 743.86%. View Second Sight Medical Products' Earnings History.

Second Sight Medical Products is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Second Sight Medical Products.

Media stories about EYES stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Second Sight Medical Products earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave news headlines about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Second Sight Medical Products.

Some companies that are related to Second Sight Medical Products include TransMedics Group (TMDX), BioLife Solutions (BLFS), Zynex (ZYXI), Stereotaxis (STXS), Semler Scientific (SMLR), BioSig Technologies (BSGM), Rockwell Medical (RMTI), Edap Tms (EDAP), Fonar (FONR), Soleno Therapeutics (SLNO), electroCore (ECOR), Fc Global Realty (FCRE), IRIDEX (IRIX), Precision Optics (PEYE) and Helius Medical Technologies (HSDT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), Cara Therapeutics (CARA), Shopify (SHOP), Opko Health (OPK), Corbus Pharmaceuticals (CRBP), VBI Vaccines (VBIV), TransEnterix (TRXC), Plug Power (PLUG) and AVEO Pharmaceuticals (AVEO).

(EYES) raised $32 million in an initial public offering on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC acted as the underwriter for the IPO.

Second Sight Medical Products' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Glassman Wealth Services (0.04%). Company insiders that own Second Sight Medical Products stock include Edward David Randolph, Gregg Williams, Jonathan Will Mcguire and Stephen D Okland. View Institutional Ownership Trends for Second Sight Medical Products.

EYES stock was sold by a variety of institutional investors in the last quarter, including Glassman Wealth Services. Company insiders that have sold Second Sight Medical Products company stock in the last year include Edward David Randolph and Jonathan Will Mcguire. View Insider Buying and Selling for Second Sight Medical Products.

Shares of EYES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EYES stock can currently be purchased for approximately $0.82.

Second Sight Medical Products has a market capitalization of $102.16 million and generates $6.90 million in revenue each year. The medical device company earns $-35,090,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. Second Sight Medical Products employs 123 workers across the globe.View Additional Information About Second Sight Medical Products.

The official website for Second Sight Medical Products is http://www.secondsight.com/.

Second Sight Medical Products' mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The medical device company can be reached via phone at 818-833-5000 or via email at [email protected]